Brigitte Michelsen
Overview
Explore the profile of Brigitte Michelsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
578
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Polysopoulos C, Georgiadis S, Ornbjerg L, Scherer A, Di Giuseppe D, Hetland M, et al.
BMC Med Res Methodol
. 2025 Feb;
25(1):55.
PMID: 40021967
Background: Observational data on composite scores often comes with missing component information. When a complete-case (CC) analysis of composite scores is unbiased, preferable approaches of dealing with missing component information...
2.
Georgiadis S, Pons M, Rasmussen S, Hetland M, Linde L, Di Giuseppe D, et al.
RMD Open
. 2025 Feb;
11(1).
PMID: 39979039
Objectives: We aimed to compare various methods for imputing disease activity in longitudinally collected observational data of patients with axial spondyloarthritis (axSpA). Methods: We conducted a simulation study on data...
3.
Pons M, Georgiadis S, Hetland M, Faizy Ahmadzay Z, Rasmussen S, Christensen S, et al.
J Rheumatol
. 2025 Feb;
PMID: 39892891
Objective: In patients with axial spondyloarthritis (axSpA) initiating secukinumab (SEC), we aimed to identify baseline (treatment start) predictors of achieving low disease activity (LDA) after 6 months, as measured by...
4.
Ciurea A, Kissling S, Gotschi A, Ornbjerg L, Rasmussen S, Tamasi B, et al.
Arthritis Res Ther
. 2025 Jan;
27(1):18.
PMID: 39891200
Background: Efficacy of tumour necrosis factor inhibitors (TNFi) for peripheral arthritis in patients with psoriatic arthritis (PsA) has been established in randomized clinical trials that have used improvement in summated...
5.
Ahmadzay Z, Heberg J, Jorgensen J, Ornbjerg L, Ostergaard M, Moller-Bisgaard S, et al.
Rheumatol Adv Pract
. 2024 Nov;
8(4):rkae135.
PMID: 39611201
Objectives: Real-world evidence is needed to inform treatment strategies for patients with PsA and axial SpA (axSpA) who have non-musculoskeletal manifestations (NMMs), various risk factors and comorbidities. International collaboration is...
6.
Pons M, Georgiadis S, Ostergaard M, Faizy Ahmadzay Z, Glintborg B, Heberg J, et al.
Joint Bone Spine
. 2024 Nov;
92(3):105824.
PMID: 39608666
Objectives: In axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) patients initiating secukinumab, we aimed to assess retention rates and proportions of patients achieving remission and low disease activity (LDA), according...
7.
Ornbjerg L, Georgiadis S, Kvien T, Michelsen B, Rasmussen S, Pavelka K, et al.
RMD Open
. 2024 Nov;
10(4).
PMID: 39489531
Objectives: To re-evaluate cut-offs for disease activity states according to the Axial Spondyloarthritis Disease Activity Score (ASDAS), and study the impact of sex, age, calendar time, disease and symptom duration...
8.
Provan S, Ljung L, Kristianslund E, Michelsen B, Uhlig T, Jonmundsson T, et al.
J Rheumatol
. 2024 Sep;
51(11):1111-1118.
PMID: 39218450
Objective: Interstitial lung disease (ILD) is one of the most common pulmonary manifestations of rheumatoid arthritis (RA), but its prevalence has not been investigated in psoriatic arthritis (PsA). The role...
9.
Glintborg B, Ostergaard M, Jorgensen J, Wallman J, Moller B, Nissen M, et al.
Rheumatology (Oxford)
. 2024 Jul;
64(1):374-376.
PMID: 39078721
No abstract available.
10.
Christiansen S, Rasmussen S, Ostergaard M, Pons M, Michelsen B, Pavelka K, et al.
RMD Open
. 2024 Jul;
10(3.
PMID: 39053949
Objectives: To compare the treatment effectiveness of secukinumab in radiographic (r) versus non-radiographic (nr) axial spondyloarthritis (axSpA) patients treated in routine care across Europe. Methods: Prospectively collected data on secukinumab-treated...